Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,778.00    -40.00 (-2.20%)
Bid:
1,782.00
Ask:
1,785.00
Spread: 3.00 (0.168%)
Market Cap: £3.49b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Directorate Change

15 Oct 2008 13:51

RNS Number : 9186F
Screen Technology Group plc
15 October 2008
 



15 October 2008

Screen Technology Group plc

("Screen Technology" or the "Company")

Directorate Change

Screen Technology announces that Tom Jarman has stepped down as Chief Executive Officer. Tom has been succeeded by Chris Hanson, Screen Technology's CFO, who has today been appointed a director of the Company.

Tom has agreed to remain an employee of the Group until early 2009 to ensure a smooth transition.

Tom has been a director of Screen Technology for almost seven years and has been CEO since 2006, during which time he has made a significant contribution to the business. Tom wishes to spend more time with his family in Gloucestershire and he and the Board agreed that it is the right time for new leadership to take the business forward.

David Christopher Hanson (50) has been Screen Technology's CFO since June 2007. Chris was previously Finance Director and then Chief Operating Officer at Cardpoint plc. He has extensive experience as a Finance Director with a number of other public companies including Parkland Group plc and JWE Telecom plc. He qualified as an accountant in 1982 and spent 13 years with KPMG.

Chris has a beneficial and family interest in 3,181,818 Screen Technology ordinary shares representing approximately 1.56 per cent of the share capital of the Company. He also has warrants to acquire a further 11,484,848 Screen Technology ordinary shares at a price of 0.66 per share.

The Board is also pleased to announce two new appointments to the Board of Screen Technology Limited, the Company's main trading subsidiary. Campbell Cromar has been appointed as Managing Director and Paul Bayley as Sales Director. Campbell is currently Chief Operating Officer of Screen Technology Limited and has 22 years experience in the digital screen market. Paul, a founder member of the Itrans team, has been with the business for 12 years and was previously Chief Technology Officer. 

Peter Smyth, Screen Technology Chairman, commented, "I would like to thank Tom for his contribution, particularly during the refinancing which took place earlier this year, and I am pleased to announce Chris as his successor. I am also very pleased to announce the changes that we have made at Screen Technology Limited which I believe will allow the business to build on the progress made to date."

Screen Technology Group plc

Peter Smyth

Chris Hanson

Tel: 01353 660250

Charles Stanley Securities 

Nominated Adviser

Russell Cook / Carl Holmes

Tel: 020 7149 6000

Chris Hanson Current Directorships

None

Chris Hanson Previous Directorships

Pharmetiq plc

Cardpoint plc

Chris Hanson was a director of John Brunton plc when it was placed into administrative receivership in July 1993. He was initially seconded from KPMG to John Brunton plc and later became a director, with a view to assisting with a turn around of the business. When it became apparent that this was not possible, John Brunton plc was placed into administrative receivership owing approximately £935,000.

There are no other details required to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGUAUUPRGPA
Date   Source Headline
15th Jan 20265:29 pmRNSTransaction in Own Shares
14th Jan 20265:35 pmRNSTransaction in Own Shares
13th Jan 20265:29 pmRNSTransaction in Own Shares
12th Jan 20265:33 pmRNSTransaction in Own Shares
9th Jan 20266:21 pmRNSTransaction in Own Shares
8th Jan 20266:31 pmRNSTransaction in Own Shares
8th Jan 20262:03 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSShare Buyback Programme
2nd Jan 202610:21 amRNSTotal Voting Rights
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
16th Dec 20251:15 pmRNSResult of AGM
15th Dec 20254:02 pmRNSDirector/PDMR Shareholding
12th Dec 20251:06 pmRNSDirector/PDMR Shareholding
10th Dec 202511:18 amRNSDirector/PDMR Shareholding
10th Dec 202511:09 amRNSDirector/PDMR Shareholding
28th Nov 20251:47 pmRNSDirector/PDMR Shareholding
28th Nov 20251:41 pmRNSDirector/PDMR Shareholding
25th Nov 202510:43 amRNSAdditional Listing
18th Nov 20257:00 amRNSQ1 2026 Trading Update
13th Nov 202511:04 amRNSBlock listing Interim Review
11th Nov 20252:29 pmRNSDirector/PDMR Shareholding
5th Nov 20251:15 pmRNSAnnual Financial Report
3rd Nov 20252:37 pmRNSTotal Voting Rights
22nd Oct 20257:00 amRNSPreliminary Results
9th Oct 20252:48 pmRNSDirector/PDMR Shareholding
23rd Sep 202510:57 amRNSHolding(s) in Company
9th Sep 20251:46 pmRNSDirector/PDMR Shareholding
28th Aug 20257:00 amRNSYear End Trading Update
11th Aug 20258:48 amRNSDirector/PDMR Shareholding
9th Jul 20259:24 amRNSDirector/PDMR Shareholding
1st Jul 20259:21 amRNSTotal Voting Rights
10th Jun 20253:07 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:30 pmRNSTotal Voting Rights
28th May 20257:00 amRNSQ3 2025 Trading Update
27th May 20259:14 amRNSDirector Declaration
15th May 20259:39 amRNSBlock listing Interim Review
9th May 202512:58 pmRNSDirector/PDMR Shareholding
1st May 20253:41 pmRNSTotal Voting Rights
8th Apr 20252:46 pmRNSDirector/PDMR Shareholding
7th Apr 20259:00 amRNSAcquisition of Oakland Group Services Ltd
1st Apr 202511:35 amRNSTotal Voting Rights
19th Mar 20257:00 amRNSHalf-year Report
13th Mar 20259:52 amRNSHolding(s) in Company
10th Mar 20252:13 pmRNSDirector/PDMR Shareholding
3rd Mar 202510:41 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSNotice of Results
10th Feb 20252:37 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20251:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.